HIV / AIDS in the News

Trump may eliminate CDC’s HIV prevention division despite risk of public health disaster - LGBTQ Nation

 

Impact of US funding cuts on the global AIDS response – 17 March 2025 update - UNAIDS

 

HIV Drug Makers Get Spooked by Possible Trump Cut, but Impact Looks Manageable - The Wall Street Journal

 

Gilead Sciences Stock Slips on Possible HIV Funding Cut - Schaeffers Research

 

Study shows significant progress in HIV treatment initiation in the Asia-Pacific region - Medical Xpress

 

No meds, no doctor: How Trump's HIV cuts hit trans Namibians - Context

 

Electronic cigarettes may pose lower cardiovascular risks for people with HIV - News-Medical.Net

 

The Trump Administration Wants to Cut Funding for HIV Prevention. Why Gilead Stock Is Falling. - Barron's

 

Stock of the Day: Gilead Sciences falls on report the Trump administration could slash funds for HIV prevention - Markets Insider

 

Impact of US funding cuts on HIV programmes in Uganda - UNAIDS

 

Stock of the Day: Gilead Sciences falls on report the Trump administration could slash funds for HIV prevention - AOL

 

Pharmalittle: We're reading about possible HIV prevention cuts, FDA warning an Africa drugmaker, and more - STAT

 

Trump Eyes Steep Cuts to CDC HIV Prevention Program - BioSpace

 

Trump’s policies threaten his 2019 vow to end HIV, experts say - Roll Call

 

Protesters gather outside Atlanta CDC; HIV division elimination rumors - FOX 5 Atlanta

 

Gilead slides as Trump administration puts HIV prevention funds under review - TradingView

 

From violence to funding cuts, Asia Pacific women living with HIV face old and new challenges - UNAIDS

 

Semaglutide May Help Improve Cognition in Adults With HIV - Medscape

 

Gilead Stock Falls on Report U.S. Could Slash HIV-Prevention Budget - The Wall Street Journal

 

GSK falls as Trump administration weighs future of CDC's HIV prevention division - TradingView

 

Cutting HIV Prevention Funding at CDC: What Would it Mean? - KFF

 

HHS may cut HIV prevention efforts at the CDC. Advocates fear changes will spike infections - Fierce healthcare

 

Emory research connected to second patient in sustained remission of HIV | Emory University | Atlanta GA - Emory News Center

 

Brooks-led research aims to improve HIV treatment of India’s transgender women - Cornell Chronicle

 

President Trump’s HIV Plan Is Too Valuable to Lose - amfAR, The Foundation for AIDS Research

 

‘It’s back to drug rationing’: the end of HIV was in sight. Then came the cuts - The Guardian

 

Mumbai pilot with HIV to challenge DGCA rider on certification - The Times of India

 

Howard Brown Health holds Women and Girls HIV/AIDS Awareness Day event - Windy City Times

 

BREAKING newsletter: Trump admin moves to end federal HIV prevention programs - Advocate.com

 

Gilead, GSK could be impacted by potential HHS HIV prevention cuts - Seeking Alpha